相似文献
1
Label-Free Receptor Assays.
Drug Discov Today Technol. 2011;7(1):e5-e11. doi: 10.1016/j.ddtec.2010.05.001.
2
Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery.
J Pharmacol Toxicol Methods. 2013 Mar-Apr;67(2):69-81. doi: 10.1016/j.vascn.2013.01.004. Epub 2013 Jan 20.
3
Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target.
PLoS One. 2011;6(10):e25643. doi: 10.1371/journal.pone.0025643. Epub 2011 Oct 7.
4
Mining the potential of label-free biosensors for seven-transmembrane receptor drug discovery.
Prog Mol Biol Transl Sci. 2013;115:123-42. doi: 10.1016/B978-0-12-394587-7.00003-8.
5
Label-free cell-based dynamic mass redistribution assays.
Curr Protoc Chem Biol. 2014 Mar 14;6(1):39-51. doi: 10.1002/9780470559277.ch130205.
6
Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors.
J Pharmacol Toxicol Methods. 2013 Nov-Dec;68(3):323-33. doi: 10.1016/j.vascn.2013.07.005. Epub 2013 Aug 9.
7
Label-free whole-cell assays: expanding the scope of GPCR screening.
Drug Discov Today. 2010 Sep;15(17-18):704-16. doi: 10.1016/j.drudis.2010.06.008. Epub 2010 Jun 23.
8
Label-free imaging and temporal signature in phenotypic cellular assays: a new approach to high-content screening.
Curr Protoc Pharmacol. 2010 Sep;Chapter 9:Unit 9.13. doi: 10.1002/0471141755.ph0913s50.
9
Label-free cell-based assays with optical biosensors in drug discovery.
Assay Drug Dev Technol. 2006 Oct;4(5):583-95. doi: 10.1089/adt.2006.4.583.
10
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family.
BMC Pharmacol Toxicol. 2013 Mar 12;14:17. doi: 10.1186/2050-6511-14-17.
引用本文的文献
1
Type 1 : A Review on Advances and Challenges in Creating Insulin Producing Devices.
Micromachines (Basel). 2023 Jan 6;14(1):151. doi: 10.3390/mi14010151.
2
Label-free cell phenotypic study of FFA4 and FFA1 and discovery of novel agonists of FFA4 from natural products.
RSC Adv. 2019 May 15;9(26):15073-15083. doi: 10.1039/c9ra02142f. eCollection 2019 May 9.
3
Raman Scattering-Based Biosensing: New Prospects and Opportunities.
Biosensors (Basel). 2021 Dec 13;11(12):512. doi: 10.3390/bios11120512.
4
Mutational Landscape of the Proglucagon-Derived Peptides.
Front Endocrinol (Lausanne). 2021 Jun 17;12:698511. doi: 10.3389/fendo.2021.698511. eCollection 2021.
5
Measuring Stepwise Binding of Thermally Fluctuating Particles to Cell Membranes without Fluorescence.
Biophys J. 2020 Apr 21;118(8):1850-1860. doi: 10.1016/j.bpj.2020.03.005. Epub 2020 Mar 14.
6
On the Measurement of Energy Dissipation of Adhered Cells with the Quartz Microbalance with Dissipation Monitoring.
Anal Chem. 2018 Sep 4;90(17):10340-10349. doi: 10.1021/acs.analchem.8b02153. Epub 2018 Aug 22.
7
A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.
Oncotarget. 2016 Nov 29;7(48):78577-78590. doi: 10.18632/oncotarget.12480.
8
Total internal reflection fluorescence quantification of receptor pharmacology.
Biosensors (Basel). 2015 Apr 27;5(2):223-40. doi: 10.3390/bios5020223.
9
Evaluating Inhibition of the Epidermal Growth Factor (EGF)-Induced Response of Mutant MCF10A Cells with an Acoustic Sensor.
Biosensors (Basel). 2012 Nov 13;2(4):448-64. doi: 10.3390/bios2040448.
10
A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling.
Biosensors (Basel). 2012 Jul 26;2(3):273-90. doi: 10.3390/bios2030273.
本文引用的文献
1
Non-invasive Optical Biosensor for Probing Cell Signaling.
Sensors (Basel). 2007 Oct 16;7(10):2316-2329. doi: 10.3390/s7102316.
2
Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7.
Mol Pharmacol. 2010 Mar;77(3):459-68. doi: 10.1124/mol.109.058768. Epub 2009 Dec 21.
3
7TM pharmacology measured by label-free: a holistic approach to cell signalling.
Curr Opin Pharmacol. 2009 Oct;9(5):643-9. doi: 10.1016/j.coph.2009.06.015. Epub 2009 Aug 9.
4
Cellular assays as portals to seven-transmembrane receptor-based drug discovery.
Nat Rev Drug Discov. 2009 Aug;8(8):617-26. doi: 10.1038/nrd2838. Epub 2009 Jul 17.
5
Label-free optical biosensor for probing integrative role of adenylyl cyclase in G protein-coupled receptor signaling.
J Recept Signal Transduct Res. 2009;29(3-4):154-62. doi: 10.1080/10799890903052544.
6
Resonant waveguide grating biosensor for whole-cell GPCR assays.
Methods Mol Biol. 2009;552:239-52. doi: 10.1007/978-1-60327-317-6_17.
7
GPR40: good cop, bad cop?
Diabetes. 2009 May;58(5):1035-6. doi: 10.2337/db09-0215.
8
The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons.
Science. 2009 Feb 13;323(5916):946-51. doi: 10.1126/science.1160649.
9
Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
J Biomol Screen. 2009 Mar;14(3):246-55. doi: 10.1177/1087057108330115. Epub 2009 Feb 11.
10
Duplexed label-free G protein--coupled receptor assays for high-throughput screening.
J Biomol Screen. 2008 Dec;13(10):975-85. doi: 10.1177/1087057108326141. Epub 2008 Nov 21.
Zotero 插件